Showing results (51-60 of 331) with videos related to
Sort By:
Pageof 34
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 23, 2008
Uveitis associated with multiple sclerosisJulie Le Scanff, Pascal Sève, Christel Renoux, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 12, 2014
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosisSandra Vukusic, Françoise Durand-Dubief, Amandine Benoit, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 13, 2016
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patientsMikael Cohen, Jérome De Sèze, Romain Marignier, et al.Plos One|July 7, 2015
Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational StudyEmmanuelle Leray, Sandra Vukusic, Marc Debouverie, et al.Journal of Neuroradiology = Journal De Neuroradiologie|May 15, 2020
Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathySylvain Rabasté, Alvaro Cobo-Calvo, Veronica Nistiriuc-Muntean, et al.Neurology|August 14, 2024
Risk of Relapse After COVID-19 Vaccination Among Patients With Multiple Sclerosis in France: A Self-Controlled Case SeriesXavier Moisset, Emmanuelle Leray, Chouki Chenaf, et al.Neurology|May 20, 2021
Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide CohortFabien Rollot, Mathieu Fauvernier, Zoe Uhry, et al.Neurology and Therapy|July 27, 2020
Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine TreatmentChristine Lebrun-Frenay, Ilona Berestjuk, Mikael Cohen, et al.Therapie|October 1, 2014
[TNF inhibitors and myelitis: think about it, even lately]Marie Stève-Dumont, Mikael Cohen, Christine Lebrun-Frenay, et al.Neurology and Therapy|August 26, 2017
A Case Report of Solitary Sclerosis: This is Really Multiple SclerosisChristine Lebrun, Mikael Cohen, Lydiane Mondot, et al.Pageof 34